WARP is a novel multimeric component of the chondrocyte pericellular matrix that interacts with perlecan

被引:37
作者
Allen, JM
Bateman, JF
Hansen, U
Wilson, R
Bruckner, P
Owens, RT
Sasaki, T
Timpl, R
Fitzgerald, J
机构
[1] Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Cell & Matrix Biol Res Unit, Parkville, Vic 3052, Australia
[2] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Parkville, Vic 3052, Australia
[3] Univ Hosp Muenster, Inst Physiol Chem & Pathobiochem, D-48129 Munster, Germany
[4] LifeCell Corp, Branchburg, NJ 08876 USA
[5] Max Planck Inst Biochem, D-82152 Martinsried, Germany
关键词
D O I
10.1074/jbc.M513746200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
WARP is a novel member of the von Willebrand factor A domain superfamily of extracellular matrix proteins that is expressed by chondrocytes. WARP is restricted to the presumptive articular cartilage zone prior to joint cavitation and to the articular cartilage and fibrocartilaginous elements in the joint, spine, and sternum during mouse embryonic development. In mature articular cartilage, WARP is highly specific for the chondrocyte pericellular microenvironment and co-localizes with perlecan, a prominent component of the chondrocyte pericellular region. WARP is present in the guanidine-soluble fraction of cartilage matrix extracts as a disulfide-bonded multimer, indicating that WARP is a strongly interacting component of the cartilage matrix. To investigate how WARP is integrated with the pericellular environment, we studied WARP binding to mouse perlecan using solid phase and surface plasmon resonance analysis. WARP interacts with domain III-2 of the perlecan core protein and the heparan sulfate chains of the perlecan domain I with K-D values in the low nanomolar range. We conclude that WARP forms macromolecular structures that interact with perlecan to contribute to the assembly and/or maintenance of "permanent" cartilage structures during development and in mature cartilages.
引用
收藏
页码:7341 / 7349
页数:9
相关论文
共 44 条
[1]   BASEMENT-MEMBRANE HEPARAN-SULFATE PROTEOGLYCAN BINDS TO LAMININ BY ITS HEPARAN-SULFATE CHAINS AND TO NIDOGEN BY SITES IN THE PROTEIN CORE [J].
BATTAGLIA, C ;
MAYER, U ;
AUMAILLEY, M ;
TIMPL, R .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1992, 208 (02) :359-366
[2]   The leucine-rich repeat protein PRELP binds perlecan and collagens and may function as a basement membrane anchor [J].
Bengtsson, E ;
Mörgelin, M ;
Sasaki, T ;
Timpl, R ;
Heinegård, D ;
Aspberg, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (17) :15061-15068
[3]   Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through α2β1 integrin [J].
Bix, G ;
Fu, J ;
Gonzalez, EM ;
Macro, L ;
Barker, A ;
Campbell, S ;
Zutter, MM ;
Santoro, SA ;
Kim, JK ;
Höök, M ;
Reed, CC ;
Iozzo, RV .
JOURNAL OF CELL BIOLOGY, 2004, 166 (01) :97-109
[4]   Structure and distribution of modules in extracellular proteins [J].
Bork, P ;
Downing, AK ;
Kieffer, B ;
Campbell, ID .
QUARTERLY REVIEWS OF BIOPHYSICS, 1996, 29 (02) :119-167
[5]   Extracellular matrix signaling: integration of form and function in normal and malignant cells [J].
Boudreau, N ;
Bissell, MJ .
CURRENT OPINION IN CELL BIOLOGY, 1998, 10 (05) :640-646
[6]  
Braissant O., 1998, BIOCHEMICA, V1, P10
[7]   The C-terminal domain V of perlecan promotes beta 1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycans [J].
Brown, JC ;
Sasaki, T ;
Gohring, W ;
Yamada, Y ;
Timpl, R .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 250 (01) :39-46
[8]   Site-directed mutagenesis of human type X collagen - Expression of alpha 1(X) NC1, NC2, and helical mutations in vitro and in transfected cells [J].
Chan, D ;
Weng, YM ;
Hocking, AM ;
Golub, S ;
McQuillan, DJ ;
Bateman, JF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (23) :13566-13572
[9]   Structural characterization of recombinant domain II of the basement membrane proteoglycan perlecan [J].
Costell, M ;
Sasaki, T ;
Mann, K ;
Yamada, Y ;
Timpl, R .
FEBS LETTERS, 1996, 396 (2-3) :127-131
[10]   Characterization of recombinant perlecan domain I and its substitution by glycosaminoglycans and oligosaccharides [J].
Costell, M ;
Mann, K ;
Yamada, Y ;
Timpl, R .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 243 (1-2) :115-121